1. World Health Organization. Global health sector strategy on viral hepatitis 2016–2021. 2016.
http://apps.who.int/iris/bitstream/handle/10665/246177/WHO-HIV-2016.06-eng.pdf;jsessionid=C9A6E8F12C8AFB281EAEDC0C2ABA6EE9?sequence=1
. Accessed 2 Apr 2018.
2. Hogenbirk R, David S, van Steenbergen J, Urbanus A. Meer dan opsporen, Nationaal hepatitisplan: een strategie voor actie. 2016.
http://www.rivm.nl/dsresource?objectid=119820d5-d1fe-440f-83cf-ffb7478f0282&type=pdf&disposition=inline
. Accessed 2 Apr 2018.
3. Lazarus JV, Wiktor S, Colombo M, Thursz M. EASL international Liver Foundation. Micro-elimination – a path to global elimination of hepatitis C. J Hepatol. 2017;67(4):665–6.
4. Health Council of the Netherlands. Screening risk groups for hepatitis B and C. The Hague: Health Council of the Netherlands; 2016.
https://www.gezondheidsraad.nl/documenten/adviezen/2016/11/01/screening-van-risicogroepen-op-hepatitis-b-en-c
. Accessed 2 Apr 2018
5. Veldhuijzen IK, Conyn-van Spaendonck MAE, Dorigo-Zetsma JW. Seroprevalence of hepatitis B and C in the Dutch population. Infect Bull. 1999;10:182–4.